De-prescribing in primary care: the clinical, ethical and psychological considerations

Waseem Jerjes; Daniel Harding

doi:10.1071/HC23118

RESEARCH ARTICLE (Open Access)

Previous Next Contents Vol 16(1)

De-prescribing in primary care: the clinical, ethical and psychological considerations

Waseem Jerjes

¹ ² ³ ^* , Daniel Harding ¹

+ Author Affiliations

- Author Affiliations

¹ North End Medical Centre, Hammersmith and Fulham Partnership, London, UK.

² Research and Development Unit, Hammersmith and Fulham Primary Care Network, London, UK.

³ Faculty of Medicine, Imperial College, London, UK.

^* Correspondence to: waseem.jerjes@nhs.net

Journal of Primary Health Care 16(1) 96-98 https://doi.org/10.1071/HC23118

Submitted: 19 September 2023 Accepted: 31 January 2024 Published: 16 February 2024

© 2024 The Author(s) (or their employer(s)). Published by CSIRO Publishing on behalf of The Royal New Zealand College of General Practitioners. This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND)

References

1 Canio WC. Polypharmacy in older adults. Clin Geriatr Med 2022; 38(4): 621-625.
| Crossref | Google Scholar | PubMed |

2 Reeve E, Gnjidic D, Long J, et al. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol 2015; 80(6): 1254-1268.
| Crossref | Google Scholar | PubMed |

3 Huffmyer MJ, Keck JW, Harrington NG, et al. Primary care clinician and community pharmacist perceptions of deprescribing. J Am Geriatr Soc 2021; 69(6): 1686-1689.
| Crossref | Google Scholar | PubMed |

4 Jyrkkä J, Enlund H, Korhonen MJ, et al. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75 study: a cross-sectional analysis. Drugs Aging 2009; 26(6): 493-503.
| Crossref | Google Scholar | PubMed |

5 O’Donnell LK, Ibrahim K. Polypharmacy and deprescribing: challenging the old and embracing the new. BMC Geriatr 2022; 22(1): 734.
| Crossref | Google Scholar |

6 Djatche L, Lee S, Singer D, et al. How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing? J Clin Pharm Ther 2018; 43(4): 550-555.
| Crossref | Google Scholar | PubMed |

7 Olesen AE, Vaever TJ, Simonsen M, et al. Deprescribing in primary care without deterioration of health-related outcomes: a real-life, quality improvement project. Basic Clin Pharmacol Toxicol 2023; 134(1): 72-82.
| Crossref | Google Scholar | PubMed |

8 Reeve E, Shakib S, Hendrix I, et al. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol 2014; 78(4): 738-747.
| Crossref | Google Scholar | PubMed |

9 Thomas RE, Thomas BC. A systematic review of studies of the STOPP/START 2015 and American Geriatric Society Beers 2015 Criteria in patients ≥ 65 years. Curr Aging Sci 2019; 12(2): 121-154.
| Crossref | Google Scholar | PubMed |

10 Cullinan S, O’Mahony D, Byrne S. Use of an e-Learning educational module to better equip doctors to prescribe for older patients: a randomised controlled trial. Drugs Aging 2017; 34(5): 367-374.
| Crossref | Google Scholar | PubMed |

11 Isenor JE, Bai I, Cormier R, et al. Deprescribing interventions in primary health care mapped to the Behaviour Change Wheel: a scoping review. Res Social Adm Pharm 2021; 17(7): 1229-1241.
| Crossref | Google Scholar | PubMed |

12 Clyne B, Cooper JA, Boland F, et al. Beliefs about prescribed medication among older patients with polypharmacy: a mixed methods study in primary care. Br J Gen Pract 2017; 67(660): e507-e518.
| Crossref | Google Scholar | PubMed |

13 Te Winkel MT, Damoiseaux-Volman BA, Abu-Hanna A, et al. Personal continuity and appropriate prescribing in primary care. Ann Fam Med 2023; 21(4): 305-312.
| Crossref | Google Scholar | PubMed |

14 Gerlach N, Michiels-Corsten M, Viniol A, et al. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study. BMC Fam Pract 2020; 21(1): 183.
| Crossref | Google Scholar | PubMed |

15 Doherty AJ, Boland P, Reed J, et al. Barriers and facilitators to deprescribing in primary care: a systematic review. BJGP Open 2020; 4(3): bjgpopen20X101096.
| Crossref | Google Scholar |

16 Purcarea VL. The impact of marketing strategies in healthcare systems. J Med Life 2019; 12(2): 93-96.
| Google Scholar |

17 Rooney K. Consumer-driven healthcare marketing: using the web to get up close and personal. J Healthc Manag 2009; 54(4): 241-251.
| Google Scholar |

18 Gillespie R, Mullan J, Harrison L. Factors which influence the deprescribing decisions of community-living older adults and GPs in Australia. Health Soc Care Community 2022; 30(6): e6206-e6216.
| Crossref | Google Scholar | PubMed |

19 Martin P, Tannenbaum C. A realist evaluation of patients’ decisions to deprescribe in the EMPOWER trial. BMJ Open 2017; 7(4): e015959.
| Crossref | Google Scholar | PubMed |

20 Weir K, Nickel B, Naganathan V, et al. Decision-making preferences and deprescribing: perspectives of older adults and companions about their medicines. J Gerontol B 2018; 73(7): e98-e107.
| Crossref | Google Scholar | PubMed |

21 Holmes HM, Todd A. The role of patient preferences in deprescribing. Clin Geriatr Med 2017; 33(2): 165-175.
| Crossref | Google Scholar | PubMed |

22 Nixon M, Kousgaard MB. Organising medication discontinuation: a qualitative study exploring the views of general practitioners toward discontinuing statins. BMC Health Serv Res 2016; 16: 226.
| Crossref | Google Scholar | PubMed |

23 Rossi MI, Young A, Maher R, et al. Polypharmacy and health beliefs in older outpatients. Am J Geriatr Pharmacother 2007; 5(4): 317-323.
| Crossref | Google Scholar | PubMed |